Golgi Transport 1A Promotes Cell Proliferation and Metastasis of Papillary Thyroid Carcinoma

KE Shuhong; XU Zhujun; ZHOU Yang; ZHENG Chenghong

doi:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240004.009

您当前的位置：

首页 >

文章列表页 >

Golgi Transport 1A Promotes Cell Proliferation and Metastasis of Papillary Thyroid Carcinoma

Preclinic Research | 更新时间：2024-02-22

- Golgi Transport 1A Promotes Cell Proliferation and Metastasis of Papillary Thyroid Carcinoma
- Journal of Sun Yat-sen University(Medical Sciences) Vol. 45, Issue 1, Pages: 69-75(2024)
- 作者机构：
  
  1.武汉市第一医院内分泌科，湖北武汉 430030
  2.武汉市第一医院肿瘤科，湖北武汉 430030
- 作者简介：
  
  ZHENG Chenghong； E-mail： 343747430@qq.com
- 基金信息：
- DOI：10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240004.009
  CLC： R736.1;R329.28;R730.21
- Published：20 January 2024，
  
  Received：26 August 2023，
  
  Accepted：27 November 2023
扫描看全文
柯淑红,徐朱俊,周杨等.高尔基运输1A蛋白促进甲状腺癌细胞的增殖和转移[J].中山大学学报（医学科学版）,2024,45(01):69-75.

KE Shuhong,XU Zhujun,ZHOU Yang,et al.Golgi Transport 1A Promotes Cell Proliferation and Metastasis of Papillary Thyroid Carcinoma[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(01):69-75.
柯淑红,徐朱俊,周杨等.高尔基运输1A蛋白促进甲状腺癌细胞的增殖和转移[J].中山大学学报（医学科学版）,2024,45(01):69-75. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240004.009.

KE Shuhong,XU Zhujun,ZHOU Yang,et al.Golgi Transport 1A Promotes Cell Proliferation and Metastasis of Papillary Thyroid Carcinoma[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(01):69-75. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240004.009.

摘要

目的

探讨高尔基运输1A蛋白（GOLT1A）在甲状腺癌细胞中的表达水平及其对甲状腺癌细胞增殖、迁移、侵袭和上皮-间充质转化（EMT）的影响。

方法

利用在线数据库肿瘤免疫评估资源（TIMER）、阿拉巴马大学伯明翰分校癌症数据分析（UALCAN）和表达谱交互分析2（GEPIA2）在线分析GOLT1A在甲状腺癌织中的表达。采用实时荧光定量PCR方法和Western blot检测人甲状腺癌细胞中GOLT1A的表达水平，CCK-8实验、集落形成实验和Transwell实验检测GOLT1A表达对人甲状腺癌细胞增殖、迁移和侵袭能力的影响，Western blot检测EMT相关基因E-钙黏蛋白（E-cadherin）、波形蛋白（vimentin）和N-钙黏蛋白（N-cadherin）表达的影响。

结果

TIMER、UALCAN及GEPIA2在线数据库分析显示，与甲状腺癌癌旁正常组织相比，GOLT1A在甲状腺癌组织中表达升高；qPCR和Western blot结果显示，与正常对照细胞相比，GOLT1A在甲状腺癌细胞系中的表达显著上调。敲低人甲状腺乳头状癌细胞TCP1细胞GOLT1A表达后，抑制细胞增殖、细胞迁移侵袭。敲低GOLT1A后TCP1细胞E-cadherin表达升高，N-cadherin和vimentin表达降低。过表达人甲状腺乳头状癌细胞BCPAP细胞GOLT1A，促进细胞增殖、迁移和侵袭。过表达GOLT1A后BCPAP细胞E-cadherin表达降低，N-cadherin和vimentin表达增加。

结论

GOLT1A在甲状腺癌中高表达，可促进甲状腺癌细胞的增殖、迁移和侵袭。

Abstract

Objective

To investigate the expression level of Golgi transport 1A （GOLT1A） in thyroid carcinoma and its effects on the proliferation， migration， invasion， and epithelial-mesenchymal transition （EMT） of thyroid carcinoma cells.

Methods

The expression of GOLT1A in thyroid carcinoma was analyzed online by tumor immune estimation resource （TIMER）， the University of Alabama at Birmingham cancer data analysis portal （UALCAN）， gene expression profiling interactive analysis 2 （GEPIA2）. The expression level of GOLT1A in thyroid carcinoma cells was detected by real-time fluorescence quantitative polymerase chain reaction （RTFQ-PCR） and western blot. Cell counting kit-8 （CCK-8） assay， colony formation assay， and transwell assay were used to detect the effects of GOLT1A expression on the proliferation， migration， and invasion of thyroid carcinoma cells. Western blot assay was used to detect the effect of GOLT1A on the expression of EMT-related genes including E-cadherin， vimentin， and N-cadherin.

Results

The online analysis of GEPIA2， TIMER， and UALCAN showed that the expression of GOLT1A was higher in thyroid carcinoma than in normal tissues， and the expression of GOLT1A in thyroid carcinoma cells was significantly higher than in normal control cells. Knockdown of GOLT1A inhibited TPC1 cell proliferation， migration， and invasion. The expression of E-cadherin increased and the expressions of N-cadherin and vimentin decreased in GOLT1A knockdown TPC1 cells. Overexpression of GOLT1A promoted BCPAP cell proliferation， migration， and invasion. The expression of E-cadherin decreased and the expressions of N-cadherin and vimentin increased in GOLT1A overexpression BCPAP cells.

Conclusion

GOLT1A is highly expressed in thyroid carcinoma and can promote the proliferation， migration， and invasion of thyroid carcinoma cells.

关键词

甲状腺癌高尔基运输1A蛋白增殖迁移侵袭

Keywords

thyroid carcinomaGolgi transport 1Aproliferationmigrationinvasion

references

Chen DW， Haymart MR. Disparities research in thyroid cancer： challenges and strategies for improvement ［J］. Thyroid， 2020， 30（9）： 1231-1235

Bray F， Ferlay J， Soerjomataram I， et al. Global cancer statistics 2018 N estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］. CA Cancer J Clin， 2018， 68（6）：394-424.

Schlumberger M， Leboulleux S. Current practice in patients with differentiated thyroid cancer ［J］. Nat Rev Endocrinol， 2021， 17（3）：176-188.

Maniakas A， Dadu R， Busaidy NL， et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma， 2000-2019 ［J］. JAMA Oncol， 2020， 6（9）： 1397-1404.

Ikeda K， Horieinour K， Ueno T， et al. miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A ［J］. Sci Rep， 2015， 5： 13170.

Zhang L， Hu R， Cheng Y， et al. Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A ［J］. Cell Prolif， 2017， 50（5）：e12364.

柯淑红，孔彩霞，徐瑶，等.circ-0092315通过调控微小RNA1256/高迁移率族蛋白A2促进甲状腺乳头状癌细胞的增殖和侵袭［J］.中国医学科学院学报，2023，45（1）：16-21

Ke SH， Kong CX， Xu Y， et al. circ_0092315 Promotes Proliferation and Invasion of Papillary Thyroid Carcinoma Cells via Regulating microRN A-1256/High Mobility Group A2 axis［J］. Zhongguo Yi Xue Ke Xue Yuan Xue Bao，2023，45（1）：16-21.

Olatunbosun ST， Huddleston BJ．Multiple endocrine neoplasia type 2：diagnostic challenges of a medullary thyroid carcinoma nodule ［J］．Int Med J， 2021， 51（7）：1188-1190.

Li Y，Feng Y，Li S，et al．Tumor invasive ability of papillary thyroid carcinomas is not conferred by acquired gene mutations ［J］．J Invest Med，2021， 69（7）：1382-1385．

林艺兰，林福生，陈国伟等. 2011—2018年厦门市甲状腺癌流行趋势和生存率分析［J］. 现代预防医学， 2021， 48（16）： 2897-2899.

Lin YL， Lin FS， Chen GW， et al. Epidemiological trend and survival analysis of thyroid cancer in Xiamen from 2011 to 2018［J］. Modern Preventive Medicine， 2021， 48（16）： 2897-2899.

Cabanillas ME， McFadden DG， Durante C. Thyroid cancer ［J］. The Lancet， 2016， 388（10061）： 2783-2795．

Ye QH， Zhu WW， Zhang JB， et al. GOLM1 modulates EGFR/RTK cellsurface recycling to drive hepatocellular carcinoma metastasis ［J］. Cancer Cell， 2016， 30：444-458.

Varambally S， Laxman B， Mehra R， et al. Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer ［J］. Neoplasia， 2008，10：1285-1294.

Song JW， Zhu J， Wu XX， et al．GOLPH3/CKAP4 promotes metastasis and tumorigenicity by enhancing the secretion of exosomal WNT3A in non-small-cell lung cancer ［J］. Cell Death Dis， 2021，12（11）：976.

Riener MO， Stenner F， Liewen H， et al. Golgi phosphoprotein 2 （GOLPH2） expression in liver tumors and its value as a serum marker in hepatocellular carcinomas ［J］. Hepatology， 2009， 49（5）：1602-1609.

Shakib H， Rajabi S， Dehghan， MH， et al. Epithelial-to-mesenchymal transition in thyroid cancer： a comprehensive review ［J］. Endocrine， 2019， 66： 435–455.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of N-cadherin on Proliferation，Migration and Invasion of Retinal Pigment Epithelial Cells

Decreased Expression of lncRNA MDC1 -AS and Its Role in Cervical Cancer

Effect of Mir-127-3p on Proliferation，Apoptosis，Migration and Invasion of Uveal Melanoma Cells via Targeting MAPK4

The Role and Mechanism of MiR-130b-5p in Down-regulating IGF-1 and Inhibiting the Migration and Invasion of Human Chorionic Trophoblast Cells

Related Author

李艳梅

LIU Xinghua

WEI Li

LIAN Hong-mei

LIU Peng

WU Shu-yi

LIU Meng-meng

XIANG Meng

Related Institution

Department of Obstetrics and Gynecology, Clinical College, Xi 'an Medical University, Xi 'an

Laboratory of Clinical Medicine, Xi 'an Medical University, Xi 'an

School of Nursing, Guangdong Pharmaceutical University

School of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University

Department of Colorectal Surgery，The Six Affiliated Hospital，Sun Yat-sen University，Guang zhou

Postal code：510080
Tel：020-87331643，87330827 Email：xbmed@mail.sysu.edu.cn
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰